# Stealth BioTherapeutics Corp. ADS (MITO)

Source: https://www.quantisnow.com/company/MITO
Generated: 2026-11-10T00:23:18.713Z

- Ticker: MITO
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2019
- Website: stealthbt.com

## About

Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate is Elamipretide that is in phase 3 clinical trial to treat barth syndrome, phase 2/3 clinical trial for the treatment of duchenne cardiomyopathy, phase 2a clinical trial to treat friedreich's ataxia, phase 2 clinical trial for the treatment of dry age-related macular degeneration, phase 2 clinical trial to treat leber's hereditary optic neuropathy, and phase 3 clinical trial for the treatment of replisome myopathies. The company's product candidates also include SBT-20 to treat complications of diabetes, renal diseases, ocular diseases, neurodegenerative, Parkinson's, Alzheimer's, Huntington's, and ALS diseases; SBT-550 for rare neurological indications; and SBT-272, a peptidomimetic that targets the mitochondria and stabilizing mitochondrial function under conditions of oxidative stress, as well as SBT 550. Stealth BioTherapeutics Corp was incorporated in 2006 and is based in George Town, the Cayman Islands.

## Latest MITO news and filings

- 2022-11-28 21:30 UTC [SEC Form 15-12G filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-stealth-biotherapeutics-corp-ads-3738300)
- 2022-11-18 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-effect-filed-by-stealth-biotherapeutics-corp-ads-3706680)
- 2022-11-18 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-effect-filed-by-stealth-biotherapeutics-corp-ads-3706679)
- 2022-11-18 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-effect-filed-by-stealth-biotherapeutics-corp-ads-3706677)
- 2022-11-16 21:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-stealth-biotherapeutics-corp-ads-3698228)
- 2022-11-16 21:21 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-stealth-biotherapeutics-corp-ads-3698224)
- 2022-11-16 21:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-stealth-biotherapeutics-corp-ads-3698193)
- 2022-11-16 21:18 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-stealth-biotherapeutics-corp-ads-3698173)
- 2022-11-16 21:15 UTC [SEC Form POS AM filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-stealth-biotherapeutics-corp-ads-3698126)
- 2022-11-16 21:13 UTC [SEC Form POS AM filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-stealth-biotherapeutics-corp-ads-3698060)
- 2022-11-16 21:10 UTC [SEC Form POS AM filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-stealth-biotherapeutics-corp-ads-3698019)
- 2022-11-16 21:08 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stealth-biotherapeutics-corp-ads-3697985)
- 2022-11-16 21:06 UTC [SEC Form SC 13E3/A filed by Stealth BioTherapeutics Corp. ADS (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-stealth-biotherapeutics-corp-ads-3697960)
- 2022-11-16 21:01 UTC [Stealth BioTherapeutics Corp Announces Completion of Merger](https://www.quantisnow.com/insight/stealth-biotherapeutics-corp-announces-completion-of-merger-3697808)
- 2022-11-16 15:05 UTC [SEC Form 25-NSE filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-stealth-biotherapeutics-corp-ads-3695940)
- 2022-11-01 11:38 UTC [Market Chatter] [Stealth BioTherapeutics Announces SBT-272 Granted Orphan Drug Designation For Treatment Of ALS](https://www.quantisnow.com/insight/stealth-biotherapeutics-announces-sbt-272-granted-orphan-drug-designation-for-treatment-3606813)
- 2022-11-01 11:30 UTC [Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)](https://www.quantisnow.com/insight/stealth-biotherapeutics-announces-sbt-272-data-updates-and-orphan-drug-designation-3606699)
- 2022-10-07 20:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stealth-biotherapeutics-corp-ads-3509287)
- 2022-10-07 20:02 UTC [SEC Form SC 13E3/A filed by Stealth BioTherapeutics Corp. ADS (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-stealth-biotherapeutics-corp-ads-3509195)
- 2022-10-07 20:01 UTC [Stealth BioTherapeutics Corp to Hold Extraordinary General Meeting of Shareholders](https://www.quantisnow.com/insight/stealth-biotherapeutics-corp-to-hold-extraordinary-general-meeting-of-shareholders-3509161)
- 2022-09-30 21:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stealth-biotherapeutics-corp-ads-3479769)
- 2022-09-30 21:00 UTC [Public Offering] [Stealth BioTherapeutics Announces Departure of Chief Financial Officer](https://www.quantisnow.com/insight/stealth-biotherapeutics-announces-departure-of-chief-financial-officer-3479648)
- 2022-09-23 21:29 UTC [SEC Form SC 13E3/A filed by Stealth BioTherapeutics Corp. ADS (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13e3a-filed-by-stealth-biotherapeutics-corp-ads-3449321)
- 2022-09-23 21:20 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Stealth BioTherapeutics Corp. ADS (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-stealth-biotherapeutics-corp-ads-3449267)
- 2022-09-15 20:45 UTC [Conference Announcement] [Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events](https://www.quantisnow.com/insight/stealth-biotherapeutics-to-participate-in-upcoming-ultra-rare-disease-events-3418650)
- 2022-08-19 20:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stealth-biotherapeutics-corp-ads-3312419)
- 2022-08-19 13:49 UTC [SEC Form SC 13E3 filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-sc-13e3-filed-by-stealth-biotherapeutics-corp-ads-3310240)
- 2022-08-05 16:23 UTC [Market Insight] [Short Volatility Alert: Stealth BioTherapeutics Corp](https://www.quantisnow.com/insight/short-volatility-alert-stealth-biotherapeutics-corp-3245783)
- 2022-08-02 09:01 UTC [Market Insight] [Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday](https://www.quantisnow.com/insight/why-revlon-shares-jumped-90-here-are-83-biggest-movers-3218211)
- 2022-08-01 22:14 UTC [Market Insight] [12 Health Care Stocks Moving In Monday's After-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-mondays-after-market-session-3217753)
- 2022-08-01 20:46 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by Stealth BioTherapeutics Corp. ADS (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-stealth-biotherapeutics-corp-ads-3216915)
- 2022-08-01 16:49 UTC [Market Insight] [This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/this-biotechnology-stock-is-trading-lower-by-77-here-are-3214763)
- 2022-08-01 16:25 UTC [Market Insight] [Stealth BioTherapeutics Enters Going Private Agreement](https://www.quantisnow.com/insight/stealth-biotherapeutics-enters-going-private-agreement-3214651)
- 2022-08-01 13:35 UTC [Market Chatter] [Stealth BioTherapeutics shares are trading higher after the company announced it has entered into a definitive agreement for a going private transaction.](https://www.quantisnow.com/insight/stealth-biotherapeutics-shares-are-trading-higher-after-the-company-announced-3213603)
- 2022-08-01 12:38 UTC [SEC Form 6-K] [SEC Form 6-K filed by Stealth BioTherapeutics Corp. ADS](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-stealth-biotherapeutics-corp-ads-3212987)
- 2022-08-01 12:33 UTC [Market Insight] [UPDATE: Pursuant To Merger Agreement, Each Stealth BioTherapeutics ADS Will Be Cancelled In Exchange For Right To Receive $0.375 In Cash](https://www.quantisnow.com/insight/update-pursuant-to-merger-agreement-each-stealth-biotherapeutics-ads-will-3212940)
- 2022-08-01 12:31 UTC [Market Insight] [Stealth BioTherapeutics Corp Enters Definitive Agreement For Going Private Transaction](https://www.quantisnow.com/insight/stealth-biotherapeutics-corp-enters-definitive-agreement-for-going-private-transaction-3212919)
- 2022-08-01 12:30 UTC [Stealth BioTherapeutics Corp Enters Definitive Agreement for Going Private Transaction](https://www.quantisnow.com/insight/stealth-biotherapeutics-corp-enters-definitive-agreement-for-going-private-transaction-3212900)
- 2022-07-31 12:52 UTC [Market Insight] [MITO: Stealth BioTherapeutics Considering Offer, While Progress Continues](https://www.quantisnow.com/insight/mito-stealth-biotherapeutics-considering-offer-while-progress-continues-3210970)
- 2022-07-26 16:02 UTC [Market Chatter] [Hearing Zacks Small-Cap Research Sets $2.05 Price Target On Stealth BioTherapeutics](https://www.quantisnow.com/insight/hearing-zacks-small-cap-research-sets-205-price-target-on-stealth-3185557)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MITO
- Earnings history: https://www.quantisnow.com/earnings/MITO
- Dividend history: https://www.quantisnow.com/dividends/MITO
- Insider transactions: https://www.quantisnow.com/insiders/MITO
- Options chain: https://www.quantisnow.com/options/MITO
- SEC 8-K filings only: https://www.quantisnow.com/company/MITO/8-k
- RSS and alerts for MITO: https://www.quantisnow.com/docs/rss-feeds.md